Simon Amy
Chief Medical Officer
Simon Amy has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jul 29, 2026.
On the most recent filing, Simon Amy is listed as Chief Medical Officer at Beam Therapeutics Inc. Inside the rolling window, Simon Amy reported no open-market purchases and 3 open-market sales totaling $607K in BEAM. The largest disclosed transaction in the window is a sale of 16,667 BEAM shares on Jul 27, 2026, worth $429K.
Companies traded
Other insiders at BEAM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$607K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Simon Amy made?
Simon Amy has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Simon Amy trade?
Simon Amy has filed SEC Form 4 disclosures for 1 company, including BEAM.
When was Simon Amy's most recent SEC Form 4 filing?
Simon Amy's most recent SEC Form 4 filing on Tracefour is dated Jul 29, 2026.
What is Simon Amy's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Simon Amy is listed as Chief Medical Officer.
What is Simon Amy's total buy and sell value in the current window?
Inside the rolling retention window, Simon Amy bought $0 and sold $607K based on SEC Form 4 filings.
What was Simon Amy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 16,667 BEAM shares on 2026-07-27, worth $429K, per SEC Form 4 filings.